About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rangrftm1.1Tke
targeted mutation 1.1, Tie Ke
MGI:7386934
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rangrftm1.1Tke/Rangrftm1.1Tke involves: C57BL/6 MGI:7387041


Genotype
MGI:7387041
hm1
Allelic
Composition
Rangrftm1.1Tke/Rangrftm1.1Tke
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rangrftm1.1Tke mutation (0 available); any Rangrf mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• focal lysis of cardiac muscle fibers
• however, no obvious inflammation or fat accumulation are seen in the heart, no differences are noted in body weight, heart weight, or heart weight to body weight ratios, and no signs of cardiac enlargement, ventricular dilation or hypertrophy are seen
• cardiac myofibrils are partially disordered, loose, ruptured and lysed in 6-month-old mice
• however, endoplasmic reticulum structure is normal
• abnormal mitochondrial morphology in cardiac ventricles, including cristae disarrangement, partial cristolysis, increased vacuoles, and a minor degree of severe membrane damage and disintegration of mitochondria
• average size of mitochondria are increased and there is an increase in the number of large mitochondria
• increase in ventricular fibrosis at 6 months of age
• dye transfer assays on heart tissue show that dye transfer distance is reduced by 39%, indicating reduced gap junction permeability
• however, no changes in cardiac sodium channel current or action potential duration in ventricular myocytes are seen
• ejection fraction and fractional shortening are reduced indicating attenuated cardiac contractile function
• echocardiography shows enlarged left ventricle end-diastolic diameter and left ventricle end-systolic diameter, and reduced ejection fraction and fractional shortening
• 3 of 6 isoproterenol-treated mice develop ventricular tachycardia and sudden cardiac death from arrest
• telemetry ECG under conscious conditions shows that 2 of 8 mice at 6 months of age display premature ventricular contractions at a rate of 60-80 beats per hour
• mice treated with the beta-receptor agonist isoproterenol, show a higher incidence of premature ventricular contractions
• 4 of 6 isoproterenol-treated mice show AV block (class I, II, III)
• mice show prolongation of QRS duration until 6 months of age and QRS prolongation is still significant at 12 months of age
• however, other ECG parameters, including heart rate, RR interval, P wave duration, PR interval, and QTc interval show no differences and no obvious arrhythmic events are seen

cellular
• cristae disarrangement in cardiac ventricles
• increase in the number of large mitochondria
• average size of mitochondria is greater in cardiac ventricles
• maker analysis of alpha-SMA expression indicates increased cardiac fibroblast activation
• marker analysis indicates a greater proliferative response of myocardial fibroblasts
• level of intracellular ATP is increased by 90%, indicating enhanced mitochondrial activity
• marker analysis suggests that dynamic balance between mitochondrial fission and fusion is disturbed with an increased trend toward mitochondrial fusion

homeostasis/metabolism
• 3 of 6 isoproterenol-treated mice develop ventricular tachycardia and sudden cardiac death from arrest
• mice treated with the beta-receptor agonist isoproterenol, show a higher incidence of premature ventricular contractions
• 4 of 6 isoproterenol-treated mice show atrioventricular (AV) block (class I, II, III)
• 3 of 6 isoproterenol-treated mice develop ventricular tachycardia and sudden cardiac death from arrest
• however, treatment with flecainide, a cardiac sodium channel blocker, shows no differences from wild-type mice
• administration of rotigaptide (ZP123), a specific Cx43 gap-junction enhancer, decreases arrhythmia inducibility in isoproterenol treated mice, with mice showing decreased incidence of premature ventricular contractions and atrioventricular block

mortality/aging
• 3 of 6 isoproterenol-treated mice develop ventricular tachycardia and sudden cardiac death from arrest

muscle
• focal lysis of cardiac muscle fibers
• however, no obvious inflammation or fat accumulation are seen in the heart, no differences are noted in body weight, heart weight, or heart weight to body weight ratios, and no signs of cardiac enlargement, ventricular dilation or hypertrophy are seen
• cardiac myofibrils are partially disordered, loose, ruptured and lysed in 6-month-old mice
• however, endoplasmic reticulum structure is normal
• ejection fraction and fractional shortening are reduced indicating attenuated cardiac contractile function
• mean cardiac sarcomere length is increased by 19%
• mean cardiac sarcomere I-band length is increased by 45%





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory